Annual Total Long Term Liabilities
$0.00
-$475.00 K-100.00%
December 31, 2023
Summary
- As of February 23, 2025, IMMX annual total long term liabilities is $0.00, with the most recent change of -$475.00 thousand (-100.00%) on December 31, 2023.
- During the last 3 years, IMMX annual total long term liabilities has risen by $0.00 (0.00%).
- IMMX annual total long term liabilities is now -100.00% below its all-time high of $475.00 thousand, reached on December 31, 2022.
Performance
IMMX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.03 M
-$16.50 K-1.58%
September 30, 2024
Summary
- As of February 23, 2025, IMMX quarterly total long term liabilities is $1.03 million, with the most recent change of -$16.50 thousand (-1.58%) on September 30, 2024.
- Over the past year, IMMX quarterly long term liabilities has stayed the same.
- IMMX quarterly long term liabilities is now -3.08% below its all-time high of $1.06 million, reached on March 31, 2024.
Performance
IMMX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IMMX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | 0.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
IMMX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -3.1% | -100.0% |
| 5 y | 5-year | -100.0% | at low | -3.1% | -100.0% |
| alltime | all time | -100.0% | at low | -3.1% | -100.0% |
Immix Biopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.03 M(-1.6%) |
| Jun 2024 | - | $1.04 M(-1.5%) |
| Mar 2024 | - | $1.06 M(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $475.00 K | $475.00 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2021 | - | $226.90 K(+9.7%) |
| Jun 2021 | - | $206.80 K(>+9900.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00 |
| Dec 2019 | $0.00 | - |
FAQ
- What is Immix Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Immix Biopharma?
- What is Immix Biopharma annual total long term liabilities year-on-year change?
- What is Immix Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Immix Biopharma?
- What is Immix Biopharma quarterly long term liabilities year-on-year change?
What is Immix Biopharma annual total long term liabilities?
The current annual total long term liabilities of IMMX is $0.00
What is the all time high annual total long term liabilities for Immix Biopharma?
Immix Biopharma all-time high annual total long term liabilities is $475.00 K
What is Immix Biopharma annual total long term liabilities year-on-year change?
Over the past year, IMMX annual total long term liabilities has changed by -$475.00 K (-100.00%)
What is Immix Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of IMMX is $1.03 M
What is the all time high quarterly long term liabilities for Immix Biopharma?
Immix Biopharma all-time high quarterly total long term liabilities is $1.06 M
What is Immix Biopharma quarterly long term liabilities year-on-year change?
Over the past year, IMMX quarterly total long term liabilities has changed by $0.00 (0.00%)